Reason behind Novavax's rise today
$Novavax(NVAX.US$ shares has approached a two-month high extending its recent gains to the fourth straight session.
Just last week, an Indian manufacturer of the company’s protein-based COVID-19 shot was allowed by the government there to export 20M doses of the vaccine to Indonesia.
The upward momentum of Novavax has also coincided with the regulatory clearance for the COVID-19 booster shots in the U.S. allowing their use in a wider segment of vaccine recipients last week.
Rising more than a tenth in value, BioNTech, the partner of $Pfizer(PFE.US$ in COVID-19 vaccine development has gained for the ninth consecutive session.
Meanwhile, Moderna has added the biggest intraday gain since early September paring back the losses made this month after revising down the sales projection for its COVID-19 vaccine.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
William Paul : $300 soon
fly up high William Paul: And $400+ by EOY imo....just a guesstimate imo.
And in 2022 when all cylinders rare working full speed, looking for $1000+ by EOY 2022.
Cheers my friend.
Long Novavax.
Indicator analyst : Novavax...
Likely rose today because of multiple catalyst's yet to come forth imo.
Geeezzz...that was a tough question..lol..smh. Humor is great for the soul.Cheers.
Drdrdoky : Been around over 10 years and still zero products.
UANM5SC6Ea : Sometimes I despair at the inaccurate information put forth on moomoo. The number of break-through COVID-19 cases of fully vaccinated people is 1 in 26,000 (CDC website today) and the average age of those people is 73, .004%. To say that the vaccine doesn't work because there are a small percentage of breakthrough infections is utterly stupid. Getting vaccinated saves lives.
Now to the question at hand: I believe Novovax's stock is going up because investors, who got shaken out of their positions by PFE's announcement of a pill to treat the disease, have quickly realized that PFE's pill doesn't end the need for ongoing vaccinations and, second, NVAX's credibility is growing as more nations approve their vaccine. Third, NVAX's COVID offering seems to protect against the 19 variety as well as four other variants.
IamTigeresssss fly up high: walau... u a bit crocodile here le....